CCND1 and neoplasm: PTHrP ablation leads to a significant decrease in tumor growth and metastasis as well as the reduced expression of several factors known to support tumor progression, including: CXCR4, Ki67, Bcl-2, AKT1, and Cyclin D1 [27].